DF
IRMD icon

DecisionPoint Financial’s iRadimed IRMD Stock Holding History

DecisionPoint Financial’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$883 Hold
9
– – ﹤0.01% 470
2026
Q1 		$867 Hold
9
– – ﹤0.01% 379
2025
Q4 		$876 Hold
9
– – ﹤0.01% 426
2025
Q3 		$634 Hold
9
– – ﹤0.01% 411
2025
Q2 		$545 Buy
+9
New +$493 ﹤0.01% 426

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DecisionPoint Financial's IRMD Position: Q2 2026 in Review

DecisionPoint Financial held its iRadimed (IRMD) position steady in Q2 2026 at 9 shares worth $883. The position accounts for ﹤0.01% of the portfolio, ranked #470.

DecisionPoint Financial first reported a position in IRMD in Q2 2025 and has held it in 5 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • DecisionPoint Financial held 9 shares of iRadimed worth $883 as of Q2 2026.
  • DecisionPoint Financial left its iRadimed share count unchanged in Q2 2026.
  • iRadimed made up ﹤0.01% of DecisionPoint Financial's portfolio in Q2 2026, its #470 holding.
  • DecisionPoint Financial first reported a position in iRadimed in Q2 2025 and has held it in 5 quarters since.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on DecisionPoint Financial's 13F filing for Q2 2026, filed 5 Aug 2026.